<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We investigated whether, in <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>), aberrant expression of miR-150/miR-221/miR-222 and their designated target <z:chebi fb="2" ids="33699">mRNA</z:chebi> molecules MYB, p27 and c-KIT may be involved in insufficient haematopoiesis </plain></SENT>
<SENT sid="1" pm="."><plain>In a series of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> (n=52), an aberrant increase of miR-150 was found only in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> with associated del(5q) (n=9; p&lt;0.01) </plain></SENT>
<SENT sid="2" pm="."><plain>The <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression of transcription factor MYB, the designated target of miR-150, was shown to correlate inversely with the miR-150 level </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0011009'>Acute</z:hpo> <z:mpath ids='MPATH_336'>leukaemia</z:mpath> evolving from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> (n=11) showed significantly decreased levels of miR-221 but not miR-222 </plain></SENT>
<SENT sid="4" pm="."><plain>We conclude that inhibition of proliferation via over-expressed miR-150 might contribute to myelodysplastic haematopoiesis in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-del(5q) </plain></SENT>
</text></document>